Abstract:Background: Ovarian epithelial tumors include benign lesions lacking invasive and metastatic abilities (cystadenomas) in addition to malignant lesions (carcinomas). An intermediate category, called tumors of low malignant potential (LMP), is also recognized. The merit of this classification is being challenged because the clinical behavior of LMP tumors appears closer to that of cystadenomas than to that of carcinomas. Purpose: To verify our hypothesis that the expression of the enzyme telomerase distinguishes these two categories of ovarian epithelial tumors, we examined and compared such expression in ovarian cystadenomas and carcinomas. By examining the expression of telomerase in LMP tumors, we then sought to determine if these tumors were more closely related to cystadenomas or to carcinomas with regard to telomerase expression. Methods: We examined a total of 64 consecutive ovarian tumors subdivided into 20 carcinomas, 17 LMP tumors, and 27 cystadenomas. We subsequently discarded three of the 27 cystadenomas because of the presence of admired normal ovarian stroma in those specimens. Tumor subtyping was done without knowledge of the telomerase results, and telomerase assays were likewise interpreted without knowledge of tumor types. Telomerase activity was determined by use of the TRAP (i.e., telomeric repeat amplification protocol) assay. Differences between the proportions of tumors expressing this enzyme in each subgroup were evaluated by use of Fisher's exact test (two-sided). Results: Telomerase activity was detected in all 20 carcinomas and in all 17 LMP tumors examined. In contrast, it was not detected in 19 of the 24 cystadenomas. These differences between rates of telomerase expression in either carcinomas or LMP tumors and those in cystadenomas were statistically significant (P<.0001). All five of the telomerase-positive cystadenomas belonged to a variant called papillary cystadenomas, whereas none of the telomerase-negative cystadenomas belonged to this variant (P<.0001). Conclusions and Implications: The presence of telomerase expression in ovarian LMP tumors supports the merit of continuing to separate these tumors from cystadenomas, in spite of their apparent benign clinical course. The finding of telomerase expression in papillary cystadenomas suggests that such tumors may be mechanistically related to LMP tumors and should perhaps be reclassified as variants of LMP tumors. Lack of telomerase expression in ovarian cystadenomas raises questions about the alleged immortality of these tumors because expression of this enzyme is thought to be essential for continuous growth in adult tumors.

The Relationship between Telomere Length and Telomerase Activity in Gynecologic Cancers

Study of Telomerase Activity in Pleural Lavage Fluid Specimens in Patients with Non-Small-cell Lung Cancer and Its Clinical Significance

Clinical Significance of Telomerase Activation and Telomeric Restriction Fragment (trf) in Cervical Cancer

[Telomerase Activity in Human Primary Endometrial Carcinoma].

Determination of Telomerase Activity in Ascites from Patients with Gynecological Malignant Tumor and Its Clinical Significance

Telomere Length in Cervical Exfoliated Cells, Interaction with HPV Genotype, and Cervical Cancer Occurrence among High‐risk HPV‐positive Women

Expression of Telomerase Activity and Its Relationship with Clinical-Pathological Factors in Epithelial Ovarian Tumors

Telomerase RNA and Telomerase Activity in Trophoblastic Tumors

Quantitative Detection of Telomerase Activity and Its Association with Clinico Pathological Characteristics in Breast Cancer

Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast.

Association of Leukocyte Telomere Length in Peripheral Blood Leukocytes with Endometrial Cancer Risk in Caucasian Americans

Telomeres and telomerase in endometrial cancer and hyperplasia

[Clinical Implications of Telomerase Activity in Breast Cancer Fine-Needle Aspirates].

Telomerase activity in benign and malignant epithelial ovarian tumors.

Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosis

[Expression of Telomerase and Telomerase Associated-Regulation Protein and Proliferating Cell Nuclear Antigen in Ovarian Epithelial Tumors].

Telomerase activity in gastric cancer and its clinical implications

Abstract 4669: Genetic variations in telomere pathway genes and ovarian cancer risk, survival and treatment response

The Association of Telomere Length and Cancer: a Meta-analysis

Telomere Length and Telomerase Activity as Potential Biomarkers for Gastrointestinal Cancer

Abstract C15: Telomere length assessment in human archival tumor tissues by quantitative PCR method